# Bacteriophage Therapy in First Time Chronic Prosthetic Joint Infections

> **NCT05269121** · PHASE1,PHASE2 · WITHDRAWN · sponsor: **Adaptive Phage Therapeutics, Inc.**

## Conditions studied

- Prosthetic Joint Infection
- Bacterial Infections

## Interventions

- **BIOLOGICAL:** Phage Therapy

## Key facts

- **NCT ID:** NCT05269121
- **Lead sponsor:** Adaptive Phage Therapeutics, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2022-09
- **Primary completion:** 2023-11
- **Final completion:** 2024-11
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** Sponsor Decision
- **Last updated:** 2024-02-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05269121

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05269121, "Bacteriophage Therapy in First Time Chronic Prosthetic Joint Infections". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT05269121. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*